82 results
8-K
EX-99.1
ABOS
Acumen Pharmaceuticals Inc
14 May 24
Acumen Pharmaceuticals Reports First Quarter 2024 Financial Results and Business Highlights
7:35am
of common shares to pay employee withholding taxes
Net cash provided by financing activities
Net change in cash and cash equivalents and restricted cash
S-8
jvz6aomc1
27 Mar 24
Registration of securities for employees
4:02pm
S-8
dft ovl7id5ctcd1
27 Mar 24
Registration of securities for employees
4:02pm
S-8
EX-5.1
f0t42rp8 wwpt
27 Mar 24
Registration of securities for employees
4:02pm
S-8
EX-23.2
xa5zo0tj0h so
27 Mar 24
Registration of securities for employees
4:02pm
424B5
j3ev3e
20 Jul 23
Prospectus supplement for primary offering
4:11pm
8-K
EX-1.1
f13jcdvv j9
20 Jul 23
Entry into a Material Definitive Agreement
4:06pm